These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20955830)

  • 1. Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.
    Craigo JK; Barnes S; Cook SJ; Issel CJ; Montelaro RC
    Vaccine; 2010 Nov; 28(51):8095-104. PubMed ID: 20955830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Envelope determinants of equine lentiviral vaccine protection.
    Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
    PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.
    Craigo JK; Ezzelarab C; Cook SJ; Liu C; Horohov D; Issel CJ; Montelaro RC
    PLoS Pathog; 2015 Jan; 11(1):e1004610. PubMed ID: 25569288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the correlation between the plasma viral load and protective immunity induced by the equine infectious anemia attenuated vaccine and its parental virulent strain].
    Cao XZ; Lin YZ; Li L; Jiang CG; Zhao LP; Lv XL; Zhou JH
    Bing Du Xue Bao; 2010 Mar; 26(2):128-33. PubMed ID: 20480642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Evolution during the development of an attenuated EIAV vaccine.
    Wang XF; Lin YZ; Li Q; Liu Q; Zhao WW; Du C; Chen J; Wang X; Zhou JH
    Retrovirology; 2016 Feb; 13():9. PubMed ID: 26842878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.
    Zhang X; Wang Y; Liang H; Wei L; Xiang W; Shen R; Shao Y
    J Gen Virol; 2007 Mar; 88(Pt 3):998-1004. PubMed ID: 17325374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
    Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
    Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.
    Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC
    J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study comparing the development of EIAV Env-specific antibodies induced by DNA/recombinant vaccinia-vectored vaccines and an attenuated Chinese EIAV vaccine.
    Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Yang K; Zhou J; Shen R; Zhang X; Shao Y
    Viral Immunol; 2012 Dec; 25(6):477-84. PubMed ID: 23171359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelope variation as a primary determinant of lentiviral vaccine efficacy.
    Craigo JK; Zhang B; Barnes S; Tagmyer TL; Cook SJ; Issel CJ; Montelaro RC
    Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15105-10. PubMed ID: 17846425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
    Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
    Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
    Jin S; Issel CJ; Montelaro RC
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.
    Craigo JK; Durkin S; Sturgeon TJ; Tagmyer T; Cook SJ; Issel CJ; Montelaro RC
    Vaccine; 2007 Jan; 25(5):834-45. PubMed ID: 17023099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
    Li F; Craigo JK; Howe L; Steckbeck JD; Cook S; Issel C; Montelaro RC
    J Virol; 2003 Jul; 77(13):7244-53. PubMed ID: 12805423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review and future perspectives on the integration characteristics for equine lentivirus in the host genome.
    Yu YY; Xu MS; Liang H; Wang HY; Yu CQ; Liu Q
    Pol J Vet Sci; 2023 Mar; 26(1):163-172. PubMed ID: 36961267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.